• Je něco špatně v tomto záznamu ?

HLA-E and HLA-F Are Overexpressed in Glioblastoma and HLA-E Increased After Exposure to Ionizing Radiation

T. Hrbac, A. Kopkova, F. Siegl, M. Vecera, M. Ruckova, T. Kazda, R. Jancalek, M. Hendrych, M. Hermanova, V. Vybihal, P. Fadrus, M. Smrcka, F. Sokol, V. Kubes, R. Lipina, O. Slaby, L. Kren, J. Sana

. 2022 ; 19 (2) : 151-162. [pub] -

Jazyk angličtina Země Řecko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22010824

BACKGROUND/AIM: Glioblastoma (GBM) is one of the deadliest human cancers responding very poorly to therapy. Although the central nervous system has been traditionally considered an immunologically privileged site with an enhanced immune response, GBM appears to benefit from this immunosuppressive milieu. Immunomodulatory molecules play an important role in immune tumor-host interactions. Non-classical human leukocyte antigens (HLA) class Ib molecules HLA-E, HLA-F, and HLA-G have been previously described to be involved in protecting semi-allogeneic fetal allografts from the maternal immune response and in transplant tolerance as well as tumoral immune escape. Unfortunately, their role in GBM remains poorly understood. Our study, therefore, aimed to characterize the relationship between the expression of these molecules in GBM on the transcriptional level and clinicopathological and molecular features of GBM as well as the effect of ionizing radiation. MATERIALS AND METHODS: We performed the analysis of HLA-E, HLA-F, and HLA-G mRNA expression in 69 GBM tissue samples and 21 non-tumor brain tissue samples (controls) by reverse transcription polymerase chain reaction. Furthermore, two primary GBM cell cultures had been irradiated to identify the effect of ionizing radiation on the expression of non-classical HLA molecules. RESULTS: Analyses revealed that both HLA-E and HLA-F are significantly up-regulated in GBM samples. Subsequent survival analysis showed a significant association between low expression of HLA-E and shorter survival of GBM patients. The dysregulated expression of both molecules was also observed between patients with methylated and unmethylated O-6-methylguanine-DNA methyltransferase (MGMT) promoter. Finally, we showed that ionizing radiation increased HLA-E expression level in GBM cells in vitro. CONCLUSION: HLA-E and HLA-F play an important role in GBM biology and could be used as diagnostic biomarkers, and in the case of HLA-E also as a prognostic biomarker.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22010824
003      
CZ-PrNML
005      
20220506131001.0
007      
ta
008      
220425s2022 gr f 000 0|eng||
009      
AR
024    7_
$a 10.21873/cgp.20311 $2 doi
035    __
$a (PubMed)35181585
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gr
100    1_
$a Hrbac, Tomas $u Department of Neurosurgery, University Hospital Ostrava, Ostrava, Czech Republic
245    10
$a HLA-E and HLA-F Are Overexpressed in Glioblastoma and HLA-E Increased After Exposure to Ionizing Radiation / $c T. Hrbac, A. Kopkova, F. Siegl, M. Vecera, M. Ruckova, T. Kazda, R. Jancalek, M. Hendrych, M. Hermanova, V. Vybihal, P. Fadrus, M. Smrcka, F. Sokol, V. Kubes, R. Lipina, O. Slaby, L. Kren, J. Sana
520    9_
$a BACKGROUND/AIM: Glioblastoma (GBM) is one of the deadliest human cancers responding very poorly to therapy. Although the central nervous system has been traditionally considered an immunologically privileged site with an enhanced immune response, GBM appears to benefit from this immunosuppressive milieu. Immunomodulatory molecules play an important role in immune tumor-host interactions. Non-classical human leukocyte antigens (HLA) class Ib molecules HLA-E, HLA-F, and HLA-G have been previously described to be involved in protecting semi-allogeneic fetal allografts from the maternal immune response and in transplant tolerance as well as tumoral immune escape. Unfortunately, their role in GBM remains poorly understood. Our study, therefore, aimed to characterize the relationship between the expression of these molecules in GBM on the transcriptional level and clinicopathological and molecular features of GBM as well as the effect of ionizing radiation. MATERIALS AND METHODS: We performed the analysis of HLA-E, HLA-F, and HLA-G mRNA expression in 69 GBM tissue samples and 21 non-tumor brain tissue samples (controls) by reverse transcription polymerase chain reaction. Furthermore, two primary GBM cell cultures had been irradiated to identify the effect of ionizing radiation on the expression of non-classical HLA molecules. RESULTS: Analyses revealed that both HLA-E and HLA-F are significantly up-regulated in GBM samples. Subsequent survival analysis showed a significant association between low expression of HLA-E and shorter survival of GBM patients. The dysregulated expression of both molecules was also observed between patients with methylated and unmethylated O-6-methylguanine-DNA methyltransferase (MGMT) promoter. Finally, we showed that ionizing radiation increased HLA-E expression level in GBM cells in vitro. CONCLUSION: HLA-E and HLA-F play an important role in GBM biology and could be used as diagnostic biomarkers, and in the case of HLA-E also as a prognostic biomarker.
650    12
$a nádory mozku $x genetika $x patologie $x radioterapie $7 D001932
650    _2
$a metylace DNA $7 D019175
650    12
$a glioblastom $x genetika $x patologie $x radioterapie $7 D005909
650    12
$a histokompatibilita - antigeny třídy I $x biosyntéza $x genetika $7 D015395
650    _2
$a lidé $7 D006801
650    _2
$a prognóza $7 D011379
650    _2
$a ionizující záření $7 D011839
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kopkova, Alena $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
700    1_
$a Siegl, Frantisek $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
700    1_
$a Vecera, Marek $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
700    1_
$a Ruckova, Michaela $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
700    1_
$a Kazda, Tomas $u Department of Radiation Oncology, Masaryk Memorial Cancer Institute and Faculty of Medicine of Masaryk University, Brno, Czech Republic
700    1_
$a Jancalek, Radim $u Department of Neurosurgery, St. Anne's University Hospital and Faculty of Medicine of Masaryk University, Brno, Czech Republic
700    1_
$a Hendrych, Michal $u First Department of Pathology, St. Anne's University Hospital and Faculty of Medicine of Masaryk University, Brno, Czech Republic
700    1_
$a Hermanova, Marketa $u First Department of Pathology, St. Anne's University Hospital and Faculty of Medicine of Masaryk University, Brno, Czech Republic
700    1_
$a Vybihal, Vaclav $u Department of Neurosurgery, University Hospital Brno, Brno, Czech Republic
700    1_
$a Fadrus, Pavel $u Department of Neurosurgery, University Hospital Brno, Brno, Czech Republic
700    1_
$a Smrcka, Martin $u Department of Neurosurgery, University Hospital Brno, Brno, Czech Republic
700    1_
$a Sokol, Filip $u Department of Pathology, University Hospital Brno, Brno, Czech Republic
700    1_
$a Kubes, Vaclav $u Department of Pathology, University Hospital Brno, Brno, Czech Republic
700    1_
$a Lipina, Radim $u Department of Neurosurgery, University Hospital Ostrava, Ostrava, Czech Republic
700    1_
$a Slaby, Ondrej $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic $u Department of Biology, Faculty of Medicine of Masaryk University, Brno, Czech Republic $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Kren, Leos $u Department of Pathology, University Hospital Brno, Brno, Czech Republic; Kren.Leos@fnbrno.cz
700    1_
$a Sana, Jiri $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic; sana.jiri@gmail.com $u Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic
773    0_
$w MED00180194 $t Cancer genomics & proteomics $x 1790-6245 $g Roč. 19, č. 2 (2022), s. 151-162
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35181585 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130953 $b ABA008
999    __
$a ok $b bmc $g 1788782 $s 1162022
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 19 $c 2 $d 151-162 $e - $i 1790-6245 $m Cancer genomics & proteomics $n Cancer Genomics Proteomics $x MED00180194
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Možnosti archivace